Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Solution NMR insights into docking interactions involving inactive ERK2.

Piserchio A, Warthaka M, Devkota AK, Kaoud TS, Lee S, Abramczyk O, Ren P, Dalby KN, Ghose R.

Biochemistry. 2011 May 10;50(18):3660-72. doi: 10.1021/bi2000559.

2.

SAXS ensemble refinement of ESCRT-III CHMP3 conformational transitions.

Różycki B, Kim YC, Hummer G.

Structure. 2011 Jan 12;19(1):109-16. doi: 10.1016/j.str.2010.10.006.

3.

Crystal structure and allosteric activation of protein kinase C βII.

Leonard TA, Różycki B, Saidi LF, Hummer G, Hurley JH.

Cell. 2011 Jan 7;144(1):55-66. doi: 10.1016/j.cell.2010.12.013.

4.

The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.

Akella R, Min X, Wu Q, Gardner KH, Goldsmith EJ.

Structure. 2010 Dec 8;18(12):1571-8. doi: 10.1016/j.str.2010.09.015.

5.

Phosphorylation of DCC by ERK2 is facilitated by direct docking of the receptor P1 domain to the kinase.

Ma W, Shang Y, Wei Z, Wen W, Wang W, Zhang M.

Structure. 2010 Nov 10;18(11):1502-11. doi: 10.1016/j.str.2010.08.011.

6.

Dynamics connect substrate recognition to catalysis in protein kinase A.

Masterson LR, Cheng C, Yu T, Tonelli M, Kornev A, Taylor SS, Veglia G.

Nat Chem Biol. 2010 Nov;6(11):821-8. doi: 10.1038/nchembio.452. Erratum in: Nat Chem Biol. 2011 May;7(5):319.

7.

Multidomain assembled states of Hck tyrosine kinase in solution.

Yang S, Blachowicz L, Makowski L, Roux B.

Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15757-62. doi: 10.1073/pnas.1004569107.

8.

Nucleotide binding to the human multidrug resistance protein 3, MRP3.

Hoffman AD, Urbatsch IL, Vogel PD.

Protein J. 2010 Jul;29(5):373-9. doi: 10.1007/s10930-010-9262-4.

PMID:
20563633
9.
10.

Pathological roles of MAPK signaling pathways in human diseases.

Kim EK, Choi EJ.

Biochim Biophys Acta. 2010 Apr;1802(4):396-405. doi: 10.1016/j.bbadis.2009.12.009. Review.

11.

Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.

Zhang J, Adrián FJ, Jahnke W, Cowan-Jacob SW, Li AG, Iacob RE, Sim T, Powers J, Dierks C, Sun F, Guo GR, Ding Q, Okram B, Choi Y, Wojciechowski A, Deng X, Liu G, Fendrich G, Strauss A, Vajpai N, Grzesiek S, Tuntland T, Liu Y, Bursulaya B, Azam M, Manley PW, Engen JR, Daley GQ, Warmuth M, Gray NS.

Nature. 2010 Jan 28;463(7280):501-6. doi: 10.1038/nature08675.

12.

Backbone NMR resonance assignment of the Abelson kinase domain in complex with imatinib.

Vajpai N, Strauss A, Fendrich G, Cowan-Jacob SW, Manley PW, Jahnke W, Grzesiek S.

Biomol NMR Assign. 2008 Jun;2(1):41-2. doi: 10.1007/s12104-008-9079-7.

PMID:
19636920
13.

Sequence-specific 1H, 13C and 15N backbone resonance assignments of the 34 kDa catalytic domain of human PTPN7.

Jeeves M, McClelland DM, Barr AJ, Overduin M.

Biomol NMR Assign. 2008 Dec;2(2):101-3. doi: 10.1007/s12104-008-9095-7.

PMID:
19636879
14.

p38alpha MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses.

Perry JJ, Harris RM, Moiani D, Olson AJ, Tainer JA.

J Mol Biol. 2009 Aug 7;391(1):1-11. doi: 10.1016/j.jmb.2009.06.005.

15.

Interface analysis of the complex between ERK2 and PTP-SL.

Balasu MC, Spiridon LN, Miron S, Craescu CT, Scheidig AJ, Petrescu AJ, Szedlacsek SE.

PLoS One. 2009;4(5):e5432. doi: 10.1371/journal.pone.0005432.

16.

Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.

Critton DA, Tortajada A, Stetson G, Peti W, Page R.

Biochemistry. 2008 Dec 16;47(50):13336-45. doi: 10.1021/bi801724n.

17.

Allosteric cooperativity in protein kinase A.

Masterson LR, Mascioni A, Traaseth NJ, Taylor SS, Veglia G.

Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):506-11. doi: 10.1073/pnas.0709214104.

18.

A novel lipid binding site formed by the MAP kinase insert in p38 alpha.

Diskin R, Engelberg D, Livnah O.

J Mol Biol. 2008 Jan 4;375(1):70-9.

PMID:
17999933
19.

Differential regulation and properties of MAPKs.

Raman M, Chen W, Cobb MH.

Oncogene. 2007 May 14;26(22):3100-12. Review.

PMID:
17496909
20.

Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism.

Kornev AP, Haste NM, Taylor SS, Eyck LF.

Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17783-8.

Items per page

Supplemental Content

Support Center